Loading clinical trials...
Loading clinical trials...
Novel Detection System for Detecting Epidermal Growth Factor Receptor Mutation in Plasma in Non-small Cell Lung Cancer
Conditions
Start Date
January 1, 2016
Primary Completion Date
January 1, 2018
Completion Date
April 1, 2018
Last Updated
January 29, 2016
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
Jian Zhang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions